Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

COVID-19

 

Bioiatriki founder dies of COVID-19

Evangelos Spanos, the founder of Greece's largest private primary care and diagnostics chain, has died from COVID-19. What's next for Bioatriki?
May 14, 2020

HBI survey shows COVID-19 impact on sector

COVID-19 has been a nightmare for most for-profit health care operators according to HBI's online survey of 100 operators internationally. That is reflected in the response which also shows the great switch to digital health.
May 14, 2020

How Covid impacts workforce, payor relations and digital health

Max Hotopf, chairman, Healthcare Business International interviews Dimitris Moulavasilis on how Diaverum, an international dialysis player present in 22 countries and four continents has reacted to Covid. We look briefly at Diaverum’s contingency planning before analysing how he sees it impacting on the business with a particular emphasis on what it means for three crucial […]
May 12, 2020

Who is raising money?

Making sense of the money markets isn't easy right now. But some big players - Ramsay, Zur Rose and TPG are still raising money and some sectors such as German outpatient are still seeing M&A consolidation.
May 7, 2020

COVID-19 will accelerate outmigration of hospital care

Italy's COVID-19 experience will place a huge new emphasis on reducing inpatient hospital stays, says Bruno Biagi, VP of the country's third-largest private hospital operator GVM Care & Research. He adds that regions will provide financial support to the private sector but the market is likely to shrink this year.
May 7, 2020

Dialysis players beat COVID-19, mostly

Global dialysis operators' volumes have been largely maintained during the COVID-19 pandemic. But the long-term impact of the crisis is not so clear. 
May 7, 2020

Statutory insurers protect their hospitals, private pay markets look bleak

The post-COVID-19 financial outlook for private hospitals in Western Europe is becoming clearer. Those in statutory insurance-funded markets are likely to be protected by the public payor while private insurers look unlikely to shoulder the burden. And reimbursement for any COVID-19 care will barely make up the difference. 
April 30, 2020
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us